Idaho gets nearly $115,000 as share of nationwide $95.5 million settlement with Sanofi-Aventis Idaho's Medicaid Division is getting nearly $115,000 as its share ...
ASK YOUR DOCTOR IF THIS AD IS RIGHT FOR YOU Does it seem like you hear the phrase "ask your doctor" every time ...
Sanofi-Aventis names pharma business head Hanspeter Spek as president of global operations French drugmaker Sanofi-Aventis says it is promoting two high-ranking executives and adding a third to its executive committee. The company is naming Hanspeter Spek as president of global operations. Spek ...
PARIS (Reuters) - Sanofi-Aventis <SASY.PA> raised its outlook for 2009 thanks to sales of swine flu vaccine and posted earnings per share growth that beat forecasts as competition from generics was offset by revenue growth for other drugs. Sanofi expected H1N1 vaccines ...
Sanofi-Aventis SA reported Friday a 6 percent rise in third-quarter profit and said strong sales of its vaccine against swine flu will drive earnings higher than expected for the full year. France's largest pharmaceutical company expects to make $500 million in sales ...
Major business events and economic events scheduled for Friday: WASHINGTON — Commerce Department releases personal income and spending for September, 8:30 a.m. WASHINGTON — Labor Department releases employment cost index for third quarter, 8:30 a.m. ST. LOUIS — Arch Coal Inc. releases ...
WASHINGTON (Reuters) - U.S. health officials are struggling to deliver vaccine against the H1N1 pandemic virus ahead of its spread but Sanofi Pasteur, one of five vaccine makers under contract, said on Friday it was on track. A spokeswoman said the company ...
A worker shows a vial of Panenza, a vaccine for the H1N1 flu virus, at a Sanofi-Pasteur production plant in Val-de-Reuil, western Paris, Monday, Oct. 19, 2009. France will begin vaccinating key medical workers against swine flu on Tuesday, Oct. 20, 2009. ...
Sanofi-Aventis signs licensing deal with Wellstat worth up to $350 million for developing drug Sanofi-Aventis is paying privately-held Wellstat Therapeutics Corp. up to $350 million under terms of a licensing deal for a potential diabetes drug, the companies said Wednesday. Wellstat is ...
LOS ANGELES (Reuters) - U.S. officials approved a new Sanofi-Aventis drug to help fight a serious complication of cancer treatment, the company said on Friday. The Food and Drug Administration approved the drug, Elitek, for managing levels of plasma uric acid (PUA) ...
A cervical cancer vaccine from GlaxoSmithKline has been authorised for sale in the United States, the British drug giant announced Friday. The US Food and Drug Administration has approved the use of Cervarix in girls and young women aged 10 to 25, ...
Children under 10 likely to need 2 doses of swine flu vaccine, tests by Sanofi show Test results of its swine flu vaccine suggest that children under 10 are likely to need two shots to be fully protected, vaccine maker Sanofi Pasteur ...
